January, Spenser E. https://orcid.org/0000-0002-5783-5581
Hagopian, Jennifer C.
Nesselhauf, Nicole M.
Progar, Kristin
Horwedel, Timothy A.
Santos, Rowena Delos
Article History
Accepted: 1 February 2021
First Online: 23 March 2021
Declarations
:
: No funding was received for this research.
: JCH and RDS have received speaking fees/honoraria from Veloxis Pharmaceuticals. RDS additionally receives compensation for consultations from Veloxis Pharmaceuticals. TAH is an employee of Veloxis Pharmaceuticals.
: This study was approved by Washington University in Saint Louis Institutional Review Board (IRB 202006037).
: Not applicable; approved with waiver of informed consent given the retrospective nature of the study.
: All authors consent to publication of this manuscript.
: Patients were required to have data for the majority of timepoints up to two years post-transplant unless censored for graft loss or death.
: Not applicable.
: SEJ, JCH, NMN, KJP participated in research design, performance of research, data analysis, and manuscript preparation. RDS participated in research design, data analysis, and manuscript preparation. TAH participated in data analysis and manuscript preparation.